# Role of Mosapride in Patients With Gastroesophageal Reflux Disease

> **NCT00729339** · PHASE4 · COMPLETED · sponsor: **Lotung Poh-Ai Hospital** · enrollment: 114 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** mosapride for the first month and placebo for the 2nd month
- **DRUG:** placebo for the first and mosapride for the second month

## Key facts

- **NCT ID:** NCT00729339
- **Lead sponsor:** Lotung Poh-Ai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2009-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00729339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00729339, "Role of Mosapride in Patients With Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00729339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*